Previous studies attribute the anticancer potential of NSAID like aspirin to the inhibition of cyclooxygenase-2 (COX2), which is upregulated in various cancer cells.15,16 Of note, an increasing body of evidence suggests that aspirin may exhibit anticancer effects in a COX-independent manner. The gene discussed is PTGS2; the disease is cancer.